[Diabetes, obesity and adenocarcinoma of corpus uteri].
Diabetes and obesity were noted in 21.3% and 42.3% respectively of 94 patients with adenocarcinoma corporis uteri. Hypertension and ovarian or mammary neoplasia were also common. Obese and diabetic subjects proved more sensitive to treatment with high doses of medroxyprogesterone acetate. Screening for precancerous states or carcinoma of the endometrium in obese and diabetic women is suggested.
D000230:Adenocarcinoma / Q000150:complications* / Q000628:therapy; D000328:Adult; D000368:Aged; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D014594:Uterine Neoplasms / Q000150:complications* / Q000628:therapy
Diabete, obesità ed adenocarcinoma corporis uteri